home / stock / lmat / lmat news


LMAT News and Press, LeMaitre Vascular Inc. From 02/26/23

Stock Information

Company Name: LeMaitre Vascular Inc.
Stock Symbol: LMAT
Market: NASDAQ
Website: lemaitre.com

Menu

LMAT LMAT Quote LMAT Short LMAT News LMAT Articles LMAT Message Board
Get LMAT Alerts

News, Short Squeeze, Breakout and More Instantly...

LMAT - LeMaitre Vascular, Inc. (LMAT) Q4 2022 Earnings Call Transcript

LeMaitre Vascular, Inc. (LMAT) Q4 2022 Earnings Conference Call February 23, 2023 17:00 ET Company Participants J.J. Pellegrino - Chief Financial Officer George LeMaitre - Chairman and Chief Executive Officer Dave Roberts - President Conference Call Participants ...

LMAT - LeMaitre Vascular, Inc. 2022 Q1 - Results - Earnings Call Presentation

The following slide deck was published by LeMaitre Vascular, Inc. in conjunction with their 2022 Q1 earnings call. For further details see: LeMaitre Vascular, Inc. 2022 Q1 - Results - Earnings Call Presentation

LMAT - LeMaitre Vascular reports mixed Q4 earnings; initiates Q1 and FY23 outlook

LeMaitre Vascular press release ( NASDAQ: LMAT ): Q4 GAAP EPS of $0.25 misses by $0.01 . Revenue of $41M (+3.8% Y/Y) in-line. Business Outlook: Q1 2023 Guidance: Sales of $42.6M - $45.0M vs. consensus $40.93M; Gross Margin of 64.8%; EPS of $0.22 - $0.27 vs. consensus $...

LMAT - LeMaitre Q4 2022 Financial Results

BURLINGTON, Mass., Feb. 23, 2023 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q4 2022 results, announced a $0.14/share quarterly dividend (+12%) and provided guidance. Q4 2022 Financial Results Sales $41.0mm, +4% (...

LMAT - LeMaitre Vascular Q4 2022 Earnings Preview

LeMaitre Vascular ( NASDAQ: LMAT ) is scheduled to announce Q4 earnings results on Thursday, February 23rd, after market close. The consensus EPS Estimate is $0.26 (-7.1% Y/Y) and the consensus Revenue Estimate is $40.99M (+3.8% Y/Y). Over the last 1 year, LMAT has beaten EP...

LMAT - Cryoport's Drop Likely Isn't Over Yet

Summary Cryoport has significantly underperformed the broader market over the past several months, largely due to poor earnings and cash flows. The company has excess cash on its books, but this doesn't make it a great prospect when you consider its continued profitability issues. A...

LMAT - LeMaitre Will Announce Fourth Quarter 2022 Earnings Results February 23, 2023

BURLINGTON, Mass., Feb. 08, 2023 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2022 financial results on Thursday, February 23, 2023, after the market close. The company has scheduled a conference call for 5:00 PM ET the same day...

LMAT - Is This Small-Cap Dividend Stock a Buy?

Buying quality dividend stocks plus patience generally equals investing success. And while dominant and leading companies are often the most well known for their quality, this characteristic isn't reserved for only these companies. Small-cap stocks can also bring satisfying investment res...

LMAT - Is This Underfollowed Dividend Stock a Buy?

Rising interest rates and fears of a global recession spooked investors, crushing many growth stocks in 2022. The sell-off helped lower the Nasdaq Composite roughly 30% so far this year. But not all growth stocks fared as poorly as those that dominate the tech-heavy index. Shares of...

LMAT - Dividend Champion, Contender, And Challenger Highlights: Week Of November 13

Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. F...

Previous 10 Next 10